Literature DB >> 2845826

Resection of pulmonary metastases from squamous carcinoma of the head and neck.

T M Mazer1, K T Robbins, M J McMurtrey, R M Byers.   

Abstract

The purpose of this study was to determine the survival results and identify favorable selection factors for a group of patients who were found to have metastatic disease from the upper aerodigestive tract to the lung and subsequently underwent pulmonary resection. The medical records of 44 patients treated at our institution were reviewed. The cumulative 5-year survival rate after pulmonary resection was 43 percent. The optimal interval between diagnosis of the primary tumor and the development of pulmonary metastases was 13 to 24 months (p less than 0.005). The most favorable primary site was the larynx. No significant prognostic effect was noted for single versus multiple metastases or T-stage of the primary tumor. The presence of intervening locoregional recurrence prior to pulmonary diagnosis likewise had no significant effect on the survival rate. The initial presence of nodal metastases and primary tumor in the oral cavity had a poor outcome. The worst prognostic indicator was the presence of mediastinal disease (p less than 0.001). We have concluded that aggressive surgical treatment for isolated pulmonary metastases from the upper aerodigestive tract in the absence of mediastinal involvement is therapeutically beneficial. Selection criteria for resection should include site and stage of primary disease, locoregional control, interval from primary to pulmonary diagnosis, extent of pulmonary disease and mediastinal involvement, and the general medical condition of the patient.

Entities:  

Mesh:

Year:  1988        PMID: 2845826     DOI: 10.1016/s0002-9610(88)80282-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.

Authors:  Steven Borson; Yongli Shuai; Barton F Branstetter; Marci Lee Nilsen; Marion A Hughes; Moon Fenton; Mark Kubik; Shaum Sridharan; David A Clump; Heath D Skinner; Jonas T Johnson; Simion I Chiosea; James Ohr; Umamaheswar Duvvuri; Seungwon Kim; Katie S Traylor; Robert Ferris; Dan P Zandberg
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-05-06

Review 2.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Pulmonary resection for metastatic head and neck cancer.

Authors:  Fengshi Chen; Makoto Sonobe; Kiyoshi Sato; Takuji Fujinaga; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 4.  Current status of pulmonary metastasectomy from primary epithelial tumors.

Authors:  Tokujiro Yano; Fumihiro Shoji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

5.  Long-term outcome and patterns of failure in patients with advanced head and neck cancer.

Authors:  Henrik Hauswald; Christian Simon; Simone Hecht; Juergen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2011-06-10       Impact factor: 3.481

6.  Survival predictors after resection of lung metastases of head or neck cancers.

Authors:  Masaya Yotsukura; Tomonari Kinoshita; Mitsutomo Kohno; Keisuke Asakura; Ikuo Kamiyama; Katsura Emoto; Yuichiro Hayashi; Takashi Ohtsuka
Journal:  Thorac Cancer       Date:  2015-01-26       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.